SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Retained Earnings

Cumulative profits kept in the business rather than paid out as dividends.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Retained Earnings · Q1 FY2026 · quarter ended Mar 2026

Retained earnings of -$118.55M in Q1 FY2026

Q1 FY2026 retained earnings was -$118.55M.

Context

  • Retained earnings amounted to 45.9% of total assets at the end of Q1 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$118.55M-13.2% QoQ
Last fiscal yearDec 2025
-$104.73M— YoY
Retained Earnings past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Retained Earnings history

USD · from the balance sheet

Latest · FY2025
(104.73M) USD
Year-over-year change
—

Retained Earnings vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so retained earnings is compared through growth and share of total assets rather than absolute size.
  • Retained earnings amounts to 45.9% of total assets for SGP, versus a peer median of 169.4%.
SGP Competitors
Retained Earnings for SGP and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ALCAlcon Inc.Sep 2026$0 USD——0.0%
SGPSpyGlass Pharma, Inc. Common StockMar 2026-$118.55M USD——45.9%
STAASTAAR Surgical CompanyApr 2026-$142.82M USD-17.3%—31.7%
SGHTSight Sciences, Inc.Mar 2026-$397.7M USD-10.3%—362.5%
OCSOculis Holding AGMar 2026-CHF 412.13M CHF-29.3%—169.4%
RXSTRxSight, Inc.Mar 2026-$676.92M USD-7.4%—222.7%
GKOSGlaukos CorporationJun 2026-$971.29M USD-24.0%—105.5%
BLCOBausch + Lomb CorporationJun 2026-$1.02B USD-20.2%—7.3%
EYPTEyePoint Pharmaceuticals, Inc.Mar 2026-$1.19B USD-29.6%—412.8%
OCULOcular Therapeutix, Inc.Mar 2026-$1.25B USD-30.4%—170.0%
Peer median (excluding SGP) —-22.1%—169.4%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.